You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Micra™ leadless pacemakers are implanted directly within the heart and do not contain leads. Less than a tenth the size of traditional pacemakers3 – comparable in size to a large vitamin capsule – Micra™ is cosmetically invisible to patients after implantation.
Patients and physicians alike are benefiting from the unique features of Micra™. Our innovative leadless pacing experience offers a streamlined and non-invasive procedure,4-5 as well as fewer complications4,5 and post-implant restrictions.6
And now, Medtronic is offering two leadless pacing options to treat a range of heart conditions.
100,000 Patients treated, in more than 60 countries2
Nippoldt D, Whiting J. Micra Transcatheter Pacing System Device Volume Characterization Comparison. November 2014. Medtronic data on file
Akatsu, Susumu. 100,000 Micra Patients Implanted. May 2021. Medtronic Data on File
Williams E, Whiting J. Micra Transcatheter Pacing System Size Comparison. November 2014. Medtronic data on file
El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm. December 2018;15(12):1800-1807.
Reynolds D, Duray GZ, Omar R, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. February 11, 2016;374(6):533-541.
Udo EO, Zuithoff NP, van Hemel NM et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. May 2012;9(5):728-735.